“The efficacy of single dose palonosetron in highly emetogenic chemotherapy protocols compared to oral aprepitant and ondansetron”, jpadr, vol. 3, no. 3, pp. 28–39, Sep. 2022, doi: 10.53411/jpadr.2022.3.3.06.